These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8692733)

  • 1. Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides.
    Hughes JA; Aronsohn AI; Avrutskaya AV; Juliano RL
    Pharm Res; 1996 Mar; 13(3):404-10. PubMed ID: 8692733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular trafficking of antisense oligonucleotides and down-regulation of bcl-2 gene expression in human melanoma cells using a fusogenic liposome delivery system.
    Hu Q; Bally MB; Madden TD
    Nucleic Acids Res; 2002 Aug; 30(16):3632-41. PubMed ID: 12177306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel graft copolymers enhance in vitro delivery of antisense oligonucleotides in the presence of serum.
    Peddada LY; Harris NK; Devore DI; Roth CM
    J Control Release; 2009 Dec; 140(2):134-40. PubMed ID: 19699243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
    J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(propylacrylic acid) enhances cationic lipid-mediated delivery of antisense oligonucleotides.
    Lee LK; Williams CL; Devore D; Roth CM
    Biomacromolecules; 2006 May; 7(5):1502-8. PubMed ID: 16677032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
    Williams SA; Chang L; Buzby JS; Suen Y; Cairo MS
    Leukemia; 1996 Dec; 10(12):1980-9. PubMed ID: 8946941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antisense nucleic acid therapy of influenza virus].
    Hatta T; Abe T; Takai K; Takaku H
    Nihon Rinsho; 1997 Oct; 55(10):2765-71. PubMed ID: 9360404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibition of human leukemia HL-60 cells by an antisense phosphodiester oligonucleotide encapsulated into fusogenic liposomes.
    Kondoh M; Matsuyama T; Suzuki R; Mizuguchi H; Nakanishi T; Nakagawa S; Tsutsumi Y; Nakanishi M; Sato M; Mayumi T
    Biol Pharm Bull; 2000 Aug; 23(8):1011-3. PubMed ID: 10963315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient nuclear delivery of antisense oligodeoxynucleotides and selective inhibition of CETP expression by apo E peptide in a human CETP-stably transfected CHO cell line.
    Liu K; Ou J; Saku K; Jimi S; Via DP; Sparrow JT; Zhang B; Pownall HJ; Smith LC; Arakawa K
    Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2207-13. PubMed ID: 10479664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on uptake, sub-cellular trafficking and efflux of antisense oligodeoxynucleotides in glioma cells using self-assembling cationic lipoplexes as delivery systems.
    Islam A; Handley SL; Thompson KS; Akhtar S
    J Drug Target; 2000; 7(5):373-82. PubMed ID: 10721799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication.
    Lavigne C; Yelle J; Sauvé G; Thierry AG
    AAPS PharmSci; 2001; 3(1):E7. PubMed ID: 11741258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific inhibition of influenza virus RNA polymerase and nucleoprotein gene expression by liposomally encapsulated antisense phosphorothioate oligonucleotides in MDCK cells.
    Abe T; Suzuki S; Hatta T; Takai K; Yokota T; Takaku H
    Antivir Chem Chemother; 1998 May; 9(3):253-62. PubMed ID: 9875404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of nuclear targeting peptide-antisense oligodeoxynucleotide conjugates.
    Reed MW; Fraga D; Schwartz DE; Scholler J; Hinrichsen RD
    Bioconjug Chem; 1995; 6(1):101-8. PubMed ID: 7711095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytosolic delivery of macromolecules: I. Synthesis and characterization of pH-sensitive acyloxyalkylimidazoles.
    Chen FJ; Asokan A; Cho MJ
    Biochim Biophys Acta; 2003 Apr; 1611(1-2):140-50. PubMed ID: 12659955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
    Wu AG; Joshi SS; Chan WC; Iversen PL; Jackson JD; Kessinger A; Pirruccello SJ; Sanger WG; Sharp JG; Verbik DJ
    Leuk Lymphoma; 1995 Dec; 20(1-2):67-76. PubMed ID: 8750625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of multidrug resistance in human leukemia cells with mdr1-targeted antisense oligonucleotides using variable treatment schedules.
    Dassow H; Lassner D; Remke H; Preiss R
    Int J Clin Pharmacol Ther; 2000 Apr; 38(4):209-16. PubMed ID: 10783831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytosolic targeting of macromolecules using a pH-dependent fusogenic peptide in combination with cationic liposomes.
    Kobayashi S; Nakase I; Kawabata N; Yu HH; Pujals S; Imanishi M; Giralt E; Futaki S
    Bioconjug Chem; 2009 May; 20(5):953-9. PubMed ID: 19388672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmable fusogenic vesicles for intracellular delivery of antisense oligodeoxynucleotides: enhanced cellular uptake and biological effects.
    Hu Q; Shew CR; Bally MB; Madden TD
    Biochim Biophys Acta; 2001 Sep; 1514(1):1-13. PubMed ID: 11513800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle-dependent distribution and specific inhibitory effect of vectorized antisense oligonucleotides in cell culture.
    Hélin V; Gottikh M; Mishal Z; Subra F; Malvy C; Lavignon M
    Biochem Pharmacol; 1999 Jul; 58(1):95-107. PubMed ID: 10403523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a pH-sensitive surfactant, dodecyl-2-(1'-imidazolyl) propionate (DIP), and preliminary studies in liposome mediated gene transfer.
    Liang E; Hughes J
    Biochim Biophys Acta; 1998 Feb; 1369(1):39-50. PubMed ID: 9528672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.